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Summary 
The killer cell inhibitory receptors  (KilLs) are surface glycoproteins expressed by natural killer 
(NK)  and T  cells that specifically recognize defined groups of polymorphic human  histocom- 
patibility leukocyte antigen  (HLA) class I molecules.  Interactions between  KilLs on NK or T 
cells and major histocompatibility  complex  (MHC)  class  I  molecules  on potential  target cells 
inhibit cell-mediated cytotoxicity, presumably by delivering a negative signal preventing lym- 
phocyte activation. In this study we examined whether KIRs also regulate cytokine production 
induced  in response to T  cell receptor-dependent  T  cell activation.  CD4 +  and  CD8 +  T  cell 
clones were stimulated by bacterial superantigens in the presence or absence ofmonoclonal an- 
tibodies  (mAbs) against the  Kilt. NKB1  or MHC  class I molecules,  and production  of tumor 
necrosis factor o~ and interferon y  was evaluated. When bacterial superantigen was presented by 
an autologous antigen-presenting  cell (APC) to a KIlL  + T  cell clone, cytokine production was 
always enhanced in the presence ofanti-MHC  class I mAb. Similarly, anti-KilL mAb also aug- 
mented cytokine production,  provided that the APC expressed a HLA class  I allele recognized 
by the  Kill..  These  results suggest that recognition  of autologous  MHC  class  I  molecules  by 
KIR+  T  cells provides  a  regulatory  mechanism  acting to  modulate  the  potency  of their  re- 
sponses to antigenic challenge. 
T 
he killer  cell inhibitory  receptors  (KilLs)  are a  family 
of structurally  related  cell  surface  molecules  that  are 
expressed on subsets of human NK and T  cells (1-3). These 
receptors  bind  to  polymorphic  HLA  class  I  glycoproteins 
(4), and this interaction prevents NK cells from killing po- 
tential target cells expressing certain HLA-B or HLA-C al- 
leles  (5-7).  lLecent  studies  suggest  that  the  Src  homology 
region 2-domain phosphatase (SHP) tyrosine phosphatase may 
be responsible for the KilL-mediated inhibition  of cytotox- 
icity  (8).  Although  structurally  unrelated,  the  Ly49  recep- 
tors expressed on mouse NK cells also recognize H-2 class I 
molecules and inhibit NK cell-mediated cytotoxicity (9). 
While  initially  discovered  on  NK  cells,  KI1Ks  are  also 
present on subsets ofT lymphocytes, including both CD4 + 
and  CD8 +  T  cells  (10-12).  The  expression  of KIlL by T 
cells is intriguing because this suggests that T  cell responses 
are regulated by two distinct, opposing receptors for MHC/ 
peptide  ligands.  Whereas  the  TClL  transmits  positive  sig- 
nals after engaging MHC/peptide  complexes, the KIlL may 
serve  to  dampen  the  extent  of cellular  activation,  thereby 
regulating  the  signaling threshold  required  for effector cell 
function.  Previously,  we  demonstrated  that  KI1Ks  can  in- 
hibit  the  lytic  function  of CTLs activated by bacterial  su- 
perantigens  (11).  Here we examine the  ability of the  KIlL 
to regulate other T  cell responses and demonstrate that dis- 
ruption  of KI1K recognition  of self-class I  molecules  leads 
to significant increases in T  cell cytokine production in re- 
sponse to superantigen stimulation. 
Materials  and Methods 
T Cell Clones and B Cell Lines.  T  cell  clones were  generated 
and maintained as described previously (13,  14). The HLA class 
I-negative B lymphoblastoid cell line (B-LCL) 721.221  was gen- 
erously provided by Dr. Robert DeMars (University of Wiscon- 
sin,  Madison,  WI)  (15).  721.221  transfectants  expressing HLA- 
B'5801 were generated as described previously (14). 
Antibodies and Flow Cytometry.  mAbs were generously provided 
by Becton Dickinson Immunocytometry Systems (San Jose, CA). 
The  anti-KItL-NKB1  mAb DX9  and anti-HLA-A,-B,-C  mAb 
DX17 were produced and characterized in our laboratory (6, 11). 
The  anti-KIN mAbs  GL183  and  EB6  mAbs were  kindly pro- 
vided by Dr. Lorenzo Moretta (University of Genoa, Genoa, It- 
aly),  and  HP-3E4  by  Dr.  Miguel  Lopez-Botet  (University  of 
Madrid,  Madrid,  Spain).  Methods of immunofluorescence stain- 
ing and flow cytometry are described elsewhere (16). 
Cytokine Assays.  T  cell clones were cultured in 96-well flat- 
bottom  microtiter  plates  (Becton  Dickinson  Labware,  Lincoln 
Park,  NJ)  with  or  without  Staphylococcus enterotoxin  B  (SEB, 
Toxin Technology  Inc.,  Sarasota,  FL).  In some assays, 721.221 
cells  or 721.221  cells  transfected with  HLA-B*5801  were  pre- 
coated with SEB,  washed to remove residual  superantigen,  and 
used as APCs at a stimulator to responder ratio of 1:1. After over- 
night incubation, triplicate 50-lxl samples  of cell-free supernatant 
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Figure  1.  KIP,,  regulation  of 
cytokine  production  by  T  cell 
clones.  (A  and  B)  A  NKB1 ~, 
CD8 +  T  cell  clone  (TC867.9) 
(I0  c'  cells/well)  was  cultured 
with  721.221  cells  or  721.221 
cells  transfected  with  HLA- 
B'5801  (10~l/well)  in  the  pres- 
ence  of control  [gG1  (anti-Leu 
19,  CD56),  anti-NKB1  (DXg), 
or anti-HLA-A,B,C  (DX17)  (10 
i~g/ml).  The  721.221  cells  and 
transfectants  were  preincubated 
with  or  without  10  ng/ml  of 
SEB  (30  nfin  at  37~  and 
washed, before coculture with T 
cells.  (C and D) The T  cell clone 
was incubated  (without 721.221 
cells)  in the presence or absence 
of 10 ng/nd of soluble SEB and 
anti-NKB1  or  anti-HLA-A,-B. 
-C  (10 p.g/ml),  as indicated. Af- 
ter  20-h  culture  at  37~  cell- 
free  supernatants  were  collected 
and  assayed  for  TNF-c~  (A  and 
(~  or  IFN-~/  (B  and  D)  by 
ELISA  (meau  of  triplicate  cul- 
tures, SI) <10%). 
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IFN-y  SEB  (ng/ml) were collected from each well and IFN-~/and TNF-cl were mea- 
sured by ELISA, as previously described (17,  18). 
Intracellular Staining.  Intracellular cytokines were detected by 
immunofluorescent  staining,  as  described  previously  (19).  PE- 
labeled  anti-TNF-et  and  FlTC-labeled  anti-IFN-y  mAb  were 
generously provided by Drs. Ken Davis and Skip Maino (Becton 
Dickinson Immunocytometry Systems)￿9 
Northern  Blot Analysis.  Northern blot analysis was performed 
as previously described  (20),  RNA  (10 ~g/lane)  was  transferred 
to nylon membranes and hybridized with a 32p-labeled KIR-NKB 1 
eDNA  probe (2).  Radioactivity was detected using a  Phosphor- 
Imager (Molecular Dynamics, Sunnyvale, CA)￿9 
Results  and  Discussion 
Superantigens are viral and bacterial proteins that activate 
T  lymphocytes by binding to MHC class II molecules on 
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APCs  and  to  the  V  region  of TCR  [3 chains  on the  re- 
sponding  T  cells  (21).  We  previously  demonstrated  that 
KIP. + CTL kill superandgen-coated class I-negative B-LCL, 
but are inhibited  when  the potential  target  cells  express a 
HLA class I  allele  reactive with  the  KIP`.  Whereas  KIP`s 
have been implicated in regulation  of cytotoxicity in both 
NK and T cells, less is known about the role of these inhib- 
itory receptors in  the regulation  of other antigen-induced 
T  cell functions,  in particular,  cytokine synthesis.  To  this 
end,  we generated KIR +, TCR.-(x/[3 + T  cell clones (both 
CD4 +  and  CD8 +)  and  selected  them  for  further  study 
based on their ability to produce cytokines in response to 
stimulation  with  SEB presented  either  by the  HLA class 
I-deficient  B-LCL 721.221  cell line  or 721.221  transfec- 
tants stably expressing certain  HLA class I  alleles.  The re- 
suits presented in Fig.  1 are from a representative CD8 + T 
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Figure 2.  SEB-induced cytokine production by KIR + and KIP,.-  T  cell clones.  For detection ofintracellu]ar cytokines,  NKB1 + (AD130.2)  (A) and 
NKB1- (T81)  (B) T cell clones were either untreated or stimulated with 10 ng/nd of soluble SEB (4 h) in the presence or absence of the control IgG1, 
anti-NKB1, or anti-HLA-A,-B,-C (10 I.tg/ml).  Cells were harvested after 4 h, fixed,  and stained with fluorochrome-conjugated control Ig, PE anti- 
TNF-~, or FITC anti-IFN-7. Data are displayed as bivariate dot plots (x and y axes, 4-decade-log scales)￿9  In samples stained with FITC- and PE-conju- 
gated IgG control mAb, >98% of cells were in the lower fight quadrant (not shown). The total percentage of cells secreting TNF-~, IFN-% or both 
cytokines (sum of upper fight, upper left, and lower right quadrants)  is indicated in each panel.  For detection of secreted  cytokines,  T  cell clones were 
cultured in the presence  of increasing concentrations of SEB for 20 h at 37~  with 10 p.g/ml of control lgGl mAb (~), anti-HLA-A,-B,-C (DX17)  (O), 
anti-NKB1 (DX9) (A), or medium (C]). TNF-c~ and IFN-'y in the cell-free supernatants  of the NKB1 + (A) or NKB1- (B) T cell clones were measured 
by ELISA (mean of triplicate  cultures,  SD <10%). 
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ognizes HLA-Bw4 ligands  (7).  In the  absence  of SEB,  no 
cytokines  were  produced  in  response  to  coculture  with 
721.221  or a 721.221  transfectant  expressing HLA-B*5801 
(a  HLA-Bw4 allele).  Higher levels  of TNF-ot  and  INF-y 
were secreted by the T  cell clone when SEB was presented 
by  the  class  I-negative  APC,  compared  with  the  HLA- 
B'5801 + transfectant  (Fig.  1, A  and B).  Suppression of cy- 
tokine  production  by the  HLA-B*5801 +  APC apparently 
is regulated by the KIR present on the T  cell clone because 
anti-NKB1  mAb or anti-MHC  class  I  mAb enhanced cy- 
tokine production to a level equal to or higher than when 
the SEB is presented by the HLA class I-negative APC. In 
parallel  with  experiments  measuring  cytokine  secretion, 
this  T  cell  clone  was  assayed  for  its  ability  to  kill  SEB- 
coated 721.221  or HLA-B*5801 +  721.221  cells,  and con- 
sistent  with  prior  findings,  the  NKB1  KIR also  inhibited 
superantigen-induced  cytotoxicity  against  targets  express- 
ing  HLA-B*5801  (not  shown).  These  results  demonstrate 
that binding of the KIR to its  class I ligand is not only ca- 
pable  of modulating T  cell-mediated  cytotoxicity but also 
has inhibitory effects on T  cell activation pathways leading 
to  lymphokine  production.  These  results  are  consistent 
with a prior study demonstrating effects ofanti-KIR mAb on 
cytokine production (10). 
Whereas studies with MHC-deficient EBV-transformed 
B-LCL cell lines  transfected with  a  single  class  I  allele  are 
useful  to  analyze  the  specificity of KIRs,  they do  not ad- 
dress the  role  of these  inhibitory receptors  in immune  re- 
sponses initiated by normal, autologous APCs. Because ac- 
tivated human T  cells express MHC  class  II, they are able 
to serve as APCs for superantigens.  Therefore, this provides 
the opportunity to study KIRs regulation ofa T  cell response 
in a  completely autologous system with  SEB presented  on 
autologous  class  II  molecules  and  KIRs  interacting  with 
self-class  I  ligands.  Preliminary  studies  demonstrated  that 
HLA-DR + human T  cell clones are capable of autopresen- 
ration  of SEB  and  that  the  response  is  blocked  by  anti- 
HLA-DR mAbs (data not shown).  To examine the role of 
KIRs in the regulation of cytokine production induced by 
autologous APCs, we selected a NKB1 + T  cell clone from 
a  HLA-Bw4  + individual  so that the KIR is  capable  of in- 
teracting  with  a  self-MHC  class  I  ligand.  These  KIR  +  T 
cells  were cultured with SEB in the presence or absence of 
anti-NKBl' or anti-HLA class  I mAbs, and cytokines were 
measured  (Fig.  1,  C  and D), When the T  cell clone auto- 
presented SEB, lymphokine production (TNF-~x and INF-',/) 
was substantially increased if self-class I recognition by the 
KIR was disrupted by either anti-NKB1 or anti-class I mAb. 
These  results  demonstrate  that interactions  between  KIRs 
and self-HLA class I molecules may regulate TCR-induced 
immune responses initiated  by autologous APCs.  It should 
be  noted that we  used  the  same  NKB1 +  T  cell  clone for 
the experiments shown in Fig.  1, A-D to directly compare 
SEB  presentation  by the  721.221  APC  (Fig.  1,  A  and  B) 
and the autologous T  cell as APC (Fig.  1,  C  and D).  Simi- 
lar results were obtained in both situations. 
Further experiments were performed to evaluate  the ki- 
netics and the effects ofsuperantigen concentration on KIR 
regulation of cytokine production. As shown in Fig. 2 A, a 
NKB 1 + CD4 + T  cell clone (AD 130.2) was stimulated with 
SEB in the presence or absence ofanti-NKB1  or anti-HLA 
class  I  mAb.  To  examine  early  time  points  in  the  SEB- 
induced response, cytokines were detected by using immu- 
nofluorescence  staining  of  intracytoplasmic  lymphokines. 
Substantially more TNF-o~ and INF-y were present in the 
cytoplasm  of KIR  +  T  cells  stimulated  in  the  presence  of 
anti-NKB1  or anti-HLA class  I mAb even within 4 h  after 
SEB activation, After overnight culture, the ability of KIRs 
to suppress cytokine secretion by SEB-activated T  cells was 
evident  at  all  concentrations  of superantigen  tested,  al- 
though at higher antigen doses the inhibition was not abso- 
lute,  implying  a  quantitative  regulation  of activation.  In 
general,  KIR regulation  of TNF-ix  production  was  more 
profound  than  control  of IFN-y secretion.  IL-2  was  not 
detected in these cultures and superantigen stimulation did 
not  induce  substantial  proliferation  under  the  conditions 
studied. 
Whereas KIRs are present on a subset ofT cells,  many T 
cell clones lack expression of these molecules. For compar- 
ison with the KIR  + T  cell clones, we selected T  cell clones 
that were unreactive with  all  existing anti-KIR rnAbs  (in- 
cluding EB6, GL183, HP-3E4, and Dxg) and did not pos- 
sess KIR transcripts as determined by Northern blot analy- 
sis  (Fig.  3).  These  KIR-  T  cells  were  evaluated  for SEB 
responsiveness in the presence or absence of anti-HLA class 
I mAb. A representative KIR  CD4 + T  cell clone (T81) is 
shown in Fig. 2  B.  In this  case, anti-HLA class I mAb had 
no effect on cytokine production induced by SEB,  consis- 
tent with the lack of  inhibitory receptor for self-HLA class I. 
Whereas the NKB1  KIRs recognize HLA-Bw4 ligands, 
other  members  of the  KIR family  react  with  HLA-C  or 
HLA-A molecules  (5,  22,  23).  KIR reactive with  HLA-C 
may also  regulate  SEB-induced  cytokine  production.  For 
example,  the  CD8 +  T  cell  clone  TC867.4  expresses  a 
GL183 KIR that presumably can interact with this individ- 
ual's HLA-Cw*0703 allele.  Consistent with this possibility, 
anti-HLA class I mAb enhanced SEB-induced cytokine pro- 
duction by this  T  cell  clone  (Table  1).  An individual  NK 
cell clone can simultaneously express two or more KIRs on 
the cell surface (22, 24). Moreover, often KIRs are present 
on NK cells  of individuals  who apparently lack self-class  I 
alleles  able  to  bind  the  receptor  (25).  Similarly,  we  have 
observed T  cell clones expressing more than one KIR and 
Figure 3.  Northern blot anal- 
ysis of KIR transcripts m T cell 
clones.  Total RNA  was  ex- 
tracted from  a  KIR  +  NK  cell 
line  (lanes  1 and  4),  from the 
KIR-  T81 T cell clone (lane 2), 
and from the AD130.2 NKB1  + 
T  cell clone  (lane  3).  The 
Northern  blot  was  hybridized 
with  32p-labeled NKB1 probe. 
Equivalent amounts of  RNA were loaded into each lane as determined by 
visual inspection of ethidium bromide~tained gels (not shown). 
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IFN-y  TNF-e~ 
KIR 
Clone  Phenotype  HLA type  expression  Medium  ecNKB1  aHLA-I  Medium  cxNKB1  cxHLA-I 
pg/ml 
TC867.9  CD8 +  A*0101, A'2902,  NKB1  223  456  427  385  1,405  1,338 
TCR-~/~  B*0801  (Bw6), 
B'1302 (Bw4) 
Cw*0603,  Cw*0703 
AD130.2  CD4 +  A3, A30,  NKB1  2,566*  8,315"  7,202*  944  6,548  5,880 
TCR-cx/~3  B49 (Bw4), B62 (Bw6), 
CW3, CW3 
TC867.4  CD8 +  A*0101, A'2902,  GL183  113  168  342  137  174  1,332 
TCR-ot/[3  B*0801  (Bw6), 
B'1302 (Bw4) 
Cw*0603,  Cw*0703 
AD169.5  CD8 +  A2, A3  NKB1,  589  474  1,287  153  102  687 
TCR-cx/~  B35 (Bw6), B50 (Bw6)  GL183 
Cw4, Cw6 
T81  CD4 +  A1, A29  None  978  946  778  2,634  2,490  1,927 
TCR-c~/[3  B8 (Bw6), B13 (Bw4) 
Cw6, Cw7 
T celt clones were analyzed by flow cytometry for their KIR expression. IFN-3~  and TNF-a were analyzed by ELISA after stimulation for 20 h with 
10 ng/rrd of SEB in the presence or absence ofanti-NKBl (DX9, 10 I~g/ml) or anti-MHC class-I (DXIT,  10 I~g/ml) mAbs. IgG1 control mAb had 
no effect on cytokine production (not shown). 
*SEB concentration  =  5 ng/ml. 
receptors  apparently  unable  to  interact  with  self-class  I 
ligands. T  cell clone AD169.5  represents a  cell expressing 
two  KIRs,  NKB1  and  GL183;  however,  this  individual 
does not express a  HLA-B or HLA-C allele known to in- 
teract  with  NKB1  or  GL183  (Table  1).  Nonetheless,  in 
functional assays,  anti-HLA class I  mAb augmented  cyto- 
kine production, suggesting that yet another KIR or inhib- 
itory receptor for a  self-class I  allele may be  expressed by 
this clone. Results from these studies indicate that the dis- 
tribution and function of KIRs on T  cells are quite similar 
to NK  cells and reveal the complexity of analyzing T  cell 
clones able to simultaneously express multiple KIRs,  only 
some of which may interact with self-class I ligands. 
In  summary,  our  findings  suggest  that  KIRs  affect  not 
only NK cell-mediated cytotoxicity, but also cytokine pro- 
duction by CD4 + and CD8 + T  cells, implying a more gen- 
eral  regulatory  role  in  the  immune  system.  The  exact 
mechanisms governing KIR expression on NK and T  ceils 
are  unclear  at  present  and  an  understanding  of how  the 
KIR  repertoire of an  individual is shaped by self-HLA is 
limited. We have observed that KIRs are preferentially ex- 
pressed on peripheral T  cells with a  "memory" phenotype 
and  are  rare  in  thymus  and  cord  blood,  suggesting  that 
these inhibitory receptors may be expressed late during dif- 
ferentiation and serve to regulate responses against antigens, 
although this remains to be proven. It is tempting to specu- 
late  that  in  the  T  cell lineage,  KIP.  may provide a  novel 
mechanism to increase the threshold of activation for effec- 
tor T  cells, thereby prohibiting stimulation due to encoun- 
ters with low affinity, self-peptide/MHC complexes. That 
these  receptors,  upon  binding to  their  class  I  ligands,  are 
able  diminish  the  potency  of T  cell responses,  suggests  a 
mechanism for limiting T  cell activation possibly operative 
in the maintenance  of tolerance or prevention of autoim- 
munity. 
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